The role of systemic handling in the pathophysiologic actions of botulinum toxin

被引:22
作者
Al-Saleem, Fetweh H. [1 ]
Ancharski, Denise M. [1 ]
Ravichandran, Easwaran [1 ]
Joshi, Suresh G. [1 ]
Singh, Ajay K. [1 ]
Gong, Yujing [1 ]
Simpson, Lance L. [1 ,2 ]
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Jefferson Med Coll, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1124/jpet.108.136242
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ability of botulinum toxin to poison cholinergic nerve transmission is a dynamic phenomenon that involves not only the actions of the toxin on the body but also the actions of the body on the toxin. The former has been the subject of intense research, whereas the latter has received almost no attention. Therefore, a series of studies were performed to characterize systemic handling of botulinum toxin. The results indicated that the toxin reaches the general circulation (transcytosis across epithelial cells) without obvious changes in structure or biological activity. The general circulation acts as a holding compartment until there is adequate fractional distribution to neuromuscular junctions to produce blockade of transmission. During its transit through this compartment, the toxin 1) undergoes little biotransformation, 2) does not accumulate significantly in circulating cells, and 3) remains largely in the free state. In naive animals, the t(1/2) for toxin in the general circulation is approximately 10 h, and at any given point in time, there is little uptake in nontarget organs (liver, kidney, heart, and lung). In immunized animals, toxin clearance from the general circulation is rapid, and there is substantial accumulation of antibody-antigen complexes in liver. Thus, enhanced clearance from the circulation is a major mechanism by which active immunization can protect against poisoning.
引用
收藏
页码:856 / 863
页数:8
相关论文
共 25 条
[21]   Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F [J].
Schmidt, JJ ;
Stafford, RG .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2003, 69 (01) :297-303
[22]   Botulism in the United States: A clinical and epidemiologic review [J].
Shapiro, RL ;
Hatheway, C ;
Swerdlow, DL .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (03) :221-228
[23]   The role of the interchain disulfide bond in governing the pharmacological actions of botulinum toxin [J].
Simpson, LL ;
Maksymowych, AB ;
Park, JB ;
Bora, RS .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (03) :857-864
[24]   Identification of the major steps in botulinum toxin action [J].
Simpson, LL .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 :167-193
[25]   Botulism [J].
Sobel, J .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (08) :1167-1173